Cochrane News

Subscribe to Cochrane News feed
Updated: 8 hours 55 min ago

Cochrane seeks Head of Review Production - Editorial and Methods Department - London, UK

Thu, 06/06/2019 - 15:05

Specifications: Full-time, permanant
Salary: Competitive
Location: London, UK
Application Closing Date: 18th July 2019 (12 Midnight GMT)

Head of Review Production for Cochrane, producer of the Cochrane Library, the world’s pre-eminent collection of high quality evidence to inform healthcare decisions.
Cochrane’s new Editor in Chief is seeking to appoint a Head of Review Production to work closely in delivering the objectives and targets of the Cochrane’s Editorial and Methods Department. 
The Head of Review Production will support the Editor in Chief by leading our global review production operations and help to implement our goal of offering high-quality, relevant, up-to-date systematic reviews and other synthesized research evidence that informs health decision-making around the world.
The successful candidate will support the strategic and editorial development of the Cochrane Library built around the needs of its users, and ensure the Library remains a premier international source of healthcare evidence.
The Head of Review Production will also work with the Cochrane Review Groups, and as a member of Cochrane’s Senior Management Team will contribute to organizational management and successful implementation of its Strategy to 2020 and future goals and objectives.
The successful candidate will have proven experience of working at a senior leadership level with strong people, project and budget management skills and expertise. Management experience within the healthcare charity sector is not essential.

Cochrane is a global, independent network of health practitioners, researchers, patient advocates and others, responding to the challenge of making vast amounts of research evidence useful for informing decisions about health. We do this by synthesizing research findings to produce the best available evidence on what can work, what might harm and where more research is needed. Our work is recognised as the international gold standard for high quality, trusted information.

If you would like to apply for this position, please send a CV along with a supporting statement to with Head of Review Production in the subject line.  The supporting statement should indicate why you are applying for the post, and how far you meet the requirements for the post outlined in the job description using specific examples.  List your experience, achievements, knowledge, personal qualities, and skills which you feel are relevant to the post.

For further information, please download the full job description from here.
Deadline for applications: 18th July 2019 (12 midnight GMT)
Interviews to be held on: (TBC)

Thursday, June 20, 2019 Category: Jobs

Featured Review: Different ways to reduce consumption of sugary drinks

Thu, 06/06/2019 - 13:34

New Cochrane Review assesses evidence on different ways to reduce consumption of sugary drinks

Consumption of sugary drinks is considered to be a key driver behind the global obesity epidemic, and is linked with tooth decay, diabetes and heart disease. Many public health bodies including the World Health Organization (WHO) have called upon governments, the food and drink industry, educational institutions, places of work and civil society to support healthier beverage choices. This new Cochrane Review summarizes evidence from research studies testing different ways of reducing consumption of sugary drinks at a population level.

A team of researchers from Germany and the UK looked at the results from 58 studies that assessed a range of approaches and strategies aimed at changing the physical or social environment where people consume or buy sugary drinks. The studies were done in a variety of settings, including schools, cafes, restaurants, homes, and retail outlets. The studies assessed a wide range of different approaches to reduce consumption such as labelling and pricing of sugar sweetened drinks and healthy alternatives. They also looked at broader policy initiatives such as community-based campaigns to encourage healthier choices. The studies were conducted in 19 different countries from North and South America, Australasia and Europe and South East Asia.

Within the broad categories of interventions studied, (labelling, nutrition standards, price increases and subsidies, home-based interventions, interventions aimed at the whole food supply, retail and food services, and intersectoral approaches such as food benefit programs and trade and investment policies), the certainty of the evidence for specific measures ranged from very low to moderate.

The review authors identified a number of measures which the available scientific evidence indicates reduces the amount of sugary drinks people drink. These measures included:

  • Labels that are easy to understand, such as ‘traffic-light’ labels, and labels that rate the healthiness of beverages with stars or numbers.
  • Limits to the availability of sugary drinks in schools.
  • Price increases on sugary drinks in restaurants, stores and leisure centres.
  • Children’s menus in chain restaurants which include healthier beverages instead of sugary drinks as the default.
  • Promotion and better placement of healthier beverages in supermarkets.
  • Government food benefits (e.g. food stamps) which cannot be used to purchase sugary drinks.
  • Community campaigns focused on supporting healthy beverage choices.
  • Measures that improve the availability of low-calorie beverages at home, e.g. through home deliveries of bottled water and diet beverages.

The Cochrane authors also found evidence that improved availability of drinking water and diet beverages at home can help people lose weight. There are also other measures which may influence how much sugary drinks people drink, but for these the available evidence is less certain.

Past research has shown that health education and taxation of sugar-sweetened beverages can also help to reduce their consumption, but these approaches were not examined in the current review. Taxation of sugary drinks, unprocessed sugar and sugar-added foods will be examined in two future Cochrane Reviews.

Review author Hans Hauner, Professor of Nutritional Medicine at Technical University Munich, Germany, and a world-leading expert in the field, commented: “Rates of obesity and diabetes are rising globally, and this trend will not be reversed without broad and effective action. Governments and industry in particular must do their part to make the healthy choice the easy choice for consumers. This review highlights key measures that can help to accomplish this.”

Review author Eva Rehfuess, Professor of Public Health and Health Services Research at LMU Munich, Germany, adds: “This review highlights essential building blocks for a comprehensive strategy to support healthy beverage choices for the whole population. However, we need to do more work to understand what works best in specific settings, such as schools and workplaces, for people of different socio-economic and cultural backgrounds, and in countries at different levels of economic development. This would help us to improve existing approaches further. Policy-makers and practioners who implement such measures should therefore cooperate with researchers to allow for high-quality evaluations.”

Review lead author Peter von Philipsborn, Research Associate at LMU Munich, Germany, said: “Sugary drinks are a global problem, and middle-income countries such as South Africa, Mexico and Brazil are particularly affected. The measures highlighted in this review should be considered by policy-makers worldwide.”

This Cochrane Review from Cochrane Public Health was conducted by researchers affiliated with the Institute of Medical Information Processing, Biometry and Epidemiology at the Pettenkofer School of Public Health at the LMU Munich, the Technical University Munich, and University College London.

Full Citation: Von Philipsborn P, Stratil JM, Burns J, Busert LK, Pfadenhauer LM, Polus S, Holzapfel C, Hauner H, Rehfuess E. Environmental interventions to reduce the consumption of sugar-sweetened beverages and their effects on health. Cochrane Database of Systematic Reviews 2019, Issue 6. Art. No.: CD012292.

Wednesday, June 12, 2019

Cochrane April - June 2019: Highlights from Q2

Wed, 05/15/2019 - 13:57

Cochrane is for anyone interested in using high-quality information to make health decisions. Whether you are a doctor or nurse, patient or carer, researcher or funder, Cochrane evidence provides a powerful tool to enhance your healthcare knowledge and decision making. Our mission is to promote evidence-informed health decision-making by producing high-quality, relevant, accessible systematic reviews and other synthesized research evidence.


April to June 2019, was a busy quarter for Cochrane! Here we provide some highlights of the second quarter of the year.

Cochrane produces high-quality, relevant, up-to-date systematic reviews, and other synthesized research evidence to inform health decision making. This quarter we released a new video that helps to explain the work of Cochrane.

David Tovey, our Cochrane Editor in Chief stepped down after 10 years of service. He shared his reflections on his time with Cochrane  and also wrote a Cochrane Library Editorial. We warmly welcomed the  appointment of a new Editor in Chief for the Cochrane Library; Dr. Karla Soares-Weiser.

This quarter, we also released a Cochrane Library Special Collection: Reducing pain in infants, children, and adolescents. The Collection, brought together the latest evidence for paediatric treatments for acute and chronic pain, to guide practice, policy, and funding. Along with the related Cochrane Editorial, it highlighted the need for more research in this area.  


Cochrane strives to produce evidence that is accessible and useful to everybody, everywhere in the world. We create Plain Language Summaries,  provide podcasts from Cochrane Review Authors, translate our work into 15 languages, and provide  Cochrane Clinical Answers.

The reach of Cochrane expanded in Q2 2019 with the  launch of Cochrane First Aid and the launch of  the Cochrane US Network. We shared Cochrane methods and evidence at the 11th Croatian Cochrane Symposium,  the first Cochrane Hong Kong Symposium and at other topic-specific academic conference such as the World Confederation for Physical Therapy. 

 Cochrane is  the ‘home of evidence' to inform health decision making. We are building greater recognition of our work and becoming the leading advocate for evidence-informed health care.

In Q2 we were  delighted to announce that Cochrane Database of Systematic Reviews Journal Impact Factor was  7.755. This means that, in 2018, a Cochrane Review was cited on average, once every 8 minutes!

Our evidence was cited and informed several guideline including the World Health Organisation Guideline on digital healthcare, the updated European Consensus Guidelines on Respiratory Distress Syndrome in preterm babies, the Wold Health Organization's cognitive decline and dementia guideline, and the Belgian Red Cross’ First Aid Guidelines for Sub-Saharan Africa. We also highlighted 7 important and impactful Cochrane Reviews with a feature on our website, an interview with the author, or a press release.

Cochrane strives to a be a diverse, inclusive, and transparent international organization that effectively harnesses the enthusiasm and skills of our contributors, is guided by our principles, governed accountably, managed efficiently, and makes optimal use of its resources.

Cochrane has created eight new Networks of Cochrane Review Groups  responsible for the efficient and timely production of high-quality systematic reviews that address the research questions that are most important to decision makers. In Q2 we started a video series to introduce these each team, what has happened so far and the ambition for what is to come.

    Planning is well underway for the Cochrane Santiago 2019 Colloquium, with the Scientific Programme being announced. This year’s scientific program is highly focused on the over-arching Colloquium theme, ‘Embracing Diversity’, which will be carried out through plenaries from global speakers, special sessions, oral presentations, and workshops. Registration is open with early bird prices until 25 July!  


      Tuesday, July 9, 2019

      Cochrane Clinical Answers

      Tue, 04/09/2019 - 19:32

      Readable, clinically-focused, actionable answers to inform point-of-care decision-making for health professionals. 

      Cochrane Clinical Answers (CCAs) provide a readable, digestible, clinically-focused entry point to rigorous research from Cochrane Reviews. They are designed to be actionable and to inform point-of-care decision-making. Each CCA contains a clinical question, a short answer, and data for the outcomes from the Cochrane Review deemed most relevant to practising healthcare professionals. The evidence is displayed in a user-friendly tabulated format that includes narratives, data, and links to graphics.

      CCAs are available with a Cochrane subscription or national license. The following CCAs will be free until the 31  August:

      Get involved: The clinical answer is written either by a practicing clinician or by a CCA Editor, with the answer being peer-reviewed by a practicing clinician. If you would like to join the Clinical Answers authoring team, please contact the team at We are specifically looking for clinicians in the following areas: Respiratory medicine, Care of the elderly, Cardiovascular medicine, Pregnancy and childbirth, Neurology - especially epilepsy, Infectious disease, Paediatrics, Rheumatology, ENT, and Urology.

      Thursday, July 4, 2019

      Endometriosis Awareness Month

      Fri, 03/22/2019 - 20:11

      March is Endometriosis Awareness Month. Endometriosis is a painful condition where endometrial tissue grows outside the uterus. It is estimated that up to 10% of women have endometriosis (Ozkan 2008).  Endometriosis can cause infertility and for women with subfertility the prevalence rate ranges from 25% to 40% (Ozkan 2008). Endometriosis frequently presents with the symptom of pain (Barlow 1993) including dysmenorrhoea (painful periods), dyspareunia (pain during sexual intercourse), and pelvic or abdominal pain.

      Cochrane Gynaecology and Fertility group has published over 20 intervention reviews and protocols investigating the effectiveness and safety of treatments for the management of endometriosis. In addition, they have published five diagnostic test accuracy reviews assessing the effectiveness of various tests in the diagnosis of endometriosis. We are joining #EndometriosisAwarenessMonth by sharing a collection of their reviews on endometriosis that focus on pain-related outcomes and fertility outcomes. The treatments include pharmacological interventions (hormonal therapy, immune-modulators, anti‐inflammatory drugs), surgery, and alternative medicine.

      Monday, March 2, 2020

      Cochrane in Practice - Round Up

      Fri, 03/22/2019 - 15:15

      Cochrane does not make clinical recommendations, instead it provides unbiased and high-quality health evidence so that health decisions, policies, and clinical guidelines can be informed by the best available evidence. ‘Cochrane Evidence in Practice’ series collects stories about clinical professionals using Cochrane evidence - the everyday healthcare professional making sure their patients and clients are getting the best care! Each piece in the series collects stories around the impact that Cochrane Review has made for a specific clinical area or clinical profession.

      Would you like to add your story about using Cochrane evidence in your practice? Please contact to share your story!

      Click on the images below to read stories of how Cochrane Evidence is being used in different clinical professions:

      Clinician stories

      Dentistry stories

      Nursing stories

      Physician Assistant stories


      Optometry stories coming soon - contact us to share your story!

      Midwifery stories coming soon - contact us to add your story!

      Wednesday, November 20, 2019

      Get Social with Cochrane!

      Wed, 03/13/2019 - 21:17

      Our Strategy to 2020 aims to put Cochrane evidence at the heart of health decision-making all over the world. This not only means making our producing high-quality and relevant systematic review but making sure that our evidence is accessible and advocating for evidence. We aim to make Cochrane the ‘home of evidence’ to inform health decision making, build greater recognition of our work, and become the leading advocate for evidence-informed health care.

      You can access Cochrane evidence in news on your favourite social media platform! Follow us on:

      Wednesday, June 12, 2019

      World Tuberculosis Day

      Wed, 02/20/2019 - 18:04

      Cochrane Library releases updated Special Collection on diagnosing tuberculosis

       World Tuberculosis Day is marked annual on 24 March as it commemorates the date in 1882 when Dr. Robert Koch announced his discovery of Mycobacterium tuberculosis, the bacillus that causes tuberculosis (TB).

      This Special Collection, curated by Cochrane contributors, includes Cochrane Reviews from the Cochrane Infectious Diseases Group and other systematic reviews from other international teams. It highlights how Cochrane evidence contributes within a wider landscape of tuberculosis evidence and guidelines. The Collection also describes key WHO guidelines on tuberculosis diagnostics, and their underpinning systematic reviews, some which are published within the WHO Guideline itself.

      This Special Collection covers:

      • Early detection of tuberculosis
      • Diagnosis of active tuberculosis disease and tuberculosis drug resistance
      • Diagnosis of tuberculosis in people living with HIV
      • Diagnosis of tuberculosis in children
      • Diagnosis of latent tuberculosis infection.


      View the Special Collection: Diagnosing Tuberculosis


      Tuesday, March 24, 2020

      World Cancer Day

      Mon, 01/14/2019 - 17:41

      World Cancer Day is an international day marked on February 4 to raise awareness of cancer and to encourage its prevention, detection, and treatment.

      Cochrane Cancer supports and coordinates the work across multiple Cochrane Review Groups dealing with the topic of Cancer. The Network is made up of six Cochrane Review Groups conducting research in Breast Cancer, Childhood Cancer, Gynaecological, Neuro-oncology and Orphan Cancers, Haematology, Lung Cancer and Urology.’  These Cochrane Review Groups provide reliable evidence required to make important decisions on issues concerning cancer and related topics. Cochrane Review Groups facilitate the identification of reports of clinical trials and carry out systematic reviews of available evidence. These are published on the Cochrane Library, and updated periodically as new evidence is identified. This ensures that Cochrane Reviews are relevant, useful, usable, and used.

      To mark World Cancer Day, we have collated a selection of  highly viewed Cochrane Reviews on cancer:

        Monday, January 27, 2020

        What are systematic reviews?

        Thu, 01/03/2019 - 00:27

         "What are systematic reviews?"

        If you’re a Cochrane contributor and have ever attempted to explain Cochrane’s work to someone, chances are you’ve tried to answer this question. And if you’re reading this because you’re new to Cochrane and the work we do, you may be wondering about this too.

        Thanks to a team of creative colleagues from Cochrane Consumers and Communication, we’re pleased to share a video resource which answers this question clearly and simply for people who may not be familiar with the concept of systematic reviews: what they are, how researchers prepare them, and why they’re an important part of making informed decisions about health - for everyone. You can find this video on Cochrane’s YouTube channel, and we hope you’ll share and spread the word about the importance of evidence!

        Monday, March 23, 2020

        Cochrane Library Special Collection: Diagnosing skin cancer

        Wed, 12/05/2018 - 10:30

        This Special Collection of Cochrane Systematic Reviews brings together a large body of research on the accuracy of tests used to diagnose skin cancer.

        Read about the Special Collection in Chinese, French, Japanese and Russian

        The suite of eleven reviews was led by Dr Jac Dinnes at the University of Birmingham and supported by the Cochrane Skin Group and a team of over 30 researchers and expert advisors, funded by the National Institute for Health Research (NIHR).   

        The reviews summarise research evidence assessing the accuracy of different diagnostic tests to support clinical and policy related decision making in the diagnosis of all types of skin cancer. 

        Dr Jac Dinnes, of the University of Birmingham’s Institute of Applied Health Research, said: “Early and accurate detection of all skin cancer types is essential to manage the disease and to improve survival rates in melanoma, especially given the rate of skin cancer world-wide is rising. 

        The visual nature of skin cancer means that it can be detected and treated in many different ways and by a number of different types of specialists, therefore the aim of these reviews is to provide the world’s best evidence for how this endemic type of cancer should be identified and treated."

        “We have found that careful consideration should be given of the technologies that could be used to make sure that skin cancers are not missed, at the same time ensuring that inappropriate referrals for specialist assessment and inappropriate excision of benign skin lesions are kept to a minimum.” 

        Key findings of the Special Collection were:

        • Visual inspection using the naked eye alone is not good enough and melanomas may be missed.
        • Smartphone applications used by people with concerns about new or changing moles or other skin lesions have a high chance of missing melanomas.
        •  When used by specialists, dermoscopy - a technique using a handheld device to zoom in on a mole and the underlying skin - is better at diagnosing melanoma than visual inspection alone, and may also help in the diagnosis of BCCs.
        •  Dermoscopy might also help GPs to correctly identify people with suspicious lesions who need to be seen by a specialist. 
        •  Dermoscopy is already widely used by dermatologists to diagnose melanoma but its use in primary care has not been widely evaluated therefore more specific research is needed.
        •  Checklists to help interpret dermoscopy might improve the accuracy of diagnosis for practitioners with less expertise and training. 
        •  Teledermatology - remote specialist assessment of skin lesions using dermoscopic images and photographs - is likely to be a good way of helping GPs to decide which skin lesions need to be seen by a skin specialist but future research needs to be better designed. 
        • Artificial intelligence techniques, such as computer-assisted diagnosis (CAD), can identify more melanomas than doctors using dermoscopy images. However, CAD systems also produce far more false positive diagnoses than dermoscopy and could lead to considerable increases in unnecessary surgery. 
        • Further research is needed on the use of specialist tests such as reflectance confocal microscopy (RCM) – a non-invasive imaging technique, which allows a clinician to do a ‘virtual biopsy’ of the skin and obtain diagnostic clues while minimising unnecessary skin biopsies.  RCM is not currently widely used in the UK but the evidence suggests that RCM may be better than dermoscopy for the diagnosis of melanoma in lesions that are difficult to diagnose.
        •  Other tests such as using high frequency ultrasound have some promise, particularly for the diagnosis of BCCs, but the evidence base is small and more work is needed.

        Cochrane Skin founder Professor Hywel Williams, of the Centre of Evidence-Based Dermatology at the University of Nottingham, said: “Completing this broad suite of detailed reviews was a real marathon. 

        “Apart from a few exceptions, I was surprised by how poor the overall study designs were, especially in terms of accurately documenting where on the clinical pathway patients were tested. 

        “Although some useful conclusions have emerged, for example, on the role of dermoscopy, the greatest value of the research is to serve as a yardstick for designing future studies evaluating skin cancer diagnosis techniques on patients who are typically seen in GP and specialist settings.”

        The research team said that future studies evaluating diagnostic skin cancer tests should recruit patients with suspicious skin lesions at the point on the clinical pathway where the test under evaluation will be used in practice. Further research is also needed to evaluate whether checklists to assist diagnosis by visual inspection alone can improve accuracy and to identify how much accuracy varies according to the level of expertise of the clinician carrying out the assessment.  Well-designed studies of dermoscopy in primary care are needed, and the best ways of delivering dermoscopy training need to be identified. 

        The reviews have been shared with The National Institute for Health and Care Excellence (NICE) to inform a potential update of the NICE Melanoma guideline, which was last updated in 2015.  

        Monday, May 25, 2020

        International Day of Persons with Disabilities

        Mon, 11/19/2018 - 19:00

        Join us December 3 to increase awareness of diverse abilities, promote inclusion for those with disabilities, and highlight Cochrane evidence around this subject.

        The United Nations recognizes International Day of Persons with Disabilities (IDPD) each year on December 3. This day increases awareness of diverse abilities and promotes inclusion for those with disabilities, and is an opportunity to highlight the latest Cochrane evidence around this subject.

        Rehabilitation is a health strategy aimed at enabling people with disabilities to reach and maintain their optimal physical, sensory, intellectual, psychological and social functional levels. Rehabilitation provides disabled people with the tools they need to attain independence and self-determination. The Cochrane Rehabilitation Field was established in 2016 and serves as a bridge between all the stakeholders in Rehabilitation and Cochrane. Cochrane Rehabilitation will on one side drive evidence and methods developed by Cochrane to the world of Rehabilitation and on the other convey priorities, needs and specificities of Rehabilitation to Cochrane.

        Tuesday, December 3, 2019

        Cochrane's 30 Under 30

        Thu, 11/01/2018 - 18:59

        Cochrane is an incredible community of people who all play their part in improving health and healthcare globally. We believe that by putting trusted evidence at the heart of health decisions we can achieve a world of improved health for all.

        Cochrane is made up of 11,000 members and over 67,000 supporters who come from more than 130 countries, worldwide. Our volunteers and contributors are researchers, health professionals, patients, carers, and people passionate about improving health outcomes for everyone, everywhere.

        Many contributors to Cochrane are young people coming from different backgrounds and cultures - from researchers, medical students, language translators and volunteers all supporting our global work. As part of highlighting Cochrane’s mission, we are recognizing the work of Cochrane’s future generation as part of this series, Cochrane’s '30 under 30.' 

        We will be hearing from young people from around the world involved in Cochrane’s work  - their backgrounds, motivation and hopes for their own and Cochrane’s future.

        Click on the pictures below to read their interviews





        Wednesday, June 19, 2019

        World Menopause Month

        Thu, 10/18/2018 - 15:28

        To raise awareness of health and menopause, the World Health Organisation and the International Menopause Society have designated October as World Menopause Month and 18 October 2019 as World Menopause Day. 

        Cochrane Gynaecology and Fertility Group has published multiple reviews assessing the effectiveness and safety of interventions in menopausal women, including peri and postmenopausal women. To celebrate World Menopause Month and Day, we have collated a selection of reviews investigating various treatments for menopausal symptoms such as hormone therapy, tibolone, relaxation, exercise, and alternative therapy.

        Tuesday, October 1, 2019

        Cochrane July - September 2019: Highlights from Q3

        Sun, 10/07/2018 - 20:53

        Cochrane is for anyone interested in using high-quality information to make health decisions. Whether you are a doctor or nurse, patient or carer, researcher or funder, Cochrane evidence provides a powerful tool to enhance your healthcare knowledge and decision making. Our mission is to promote evidence-informed health decision-making by producing high-quality, relevant, accessible systematic reviews and other synthesized research evidence.


        July to September 2019, was a busy quarter for Cochrane! Here we provide some highlights of the third quarter of the year.

        Cochrane produces high-quality, relevant, up-to-date systematic reviews, and other synthesized research evidence to inform health decision making. This quarter we were deleted to hear that Professor Julian Higgins  received the 2019 Extraordinary Service Award at the Society for Research Synthesis Methodology 2019 Annual Meeting. Julian also has a long-standing history in Cochrane, contributing to the development of methods that are integral to the Reviews Cochrane produces.

        An article was published in Nature, 'Out of date before it's published' which looked at how Cochrane is keeping pace with fast-moving research fields. It featured the work of Cochrane to increase the speed and efficiency of Cochrane systematic review production. Another article in the Journal of Orthopaedic & Sports Physical Therapy comparing low back pain systematic review abstracts to their full text. It found that  "Cochrane review abstracts had substantial to almost perfect agreement with the full text"

        Cochrane strives to produce evidence that is accessible and useful to everybody, everywhere in the world. We create Plain Language Summaries,  provide podcasts from Cochrane Review Authors, translate our work into 15 languages, and provide  Cochrane Clinical Answers.

        The British Medical Journal 'Talk Medicine' podcast featured the work of Cochrane Austria in the Podcast "Fighting bad science in Austria". Gerald Gartlehner, Director of Cochrane Austria, explained how they are testing the truth of medical statements made in the media in order to support readers, patients, doctors, and decision-makers to critically analyze the information they encounter. The Skeptics' Guide to EM podcast talked to the Cochrane Acute and Emergency Care Network about their work and Cochrane. An article highlighting an innovative approach developed by WHO and Cochrane to ensure that global recommendations on maternal and perinatal health are up to date was recently published in BMJ Global Health.

         Cochrane is the ‘home of evidence' to inform health decision making. We are building greater recognition of our work and becoming the leading advocate for evidence-informed health care.

        During Q3,  Cochrane started work on a series of advocacy priorities for 2020 and 2021. Cochrane’s Editor in Chief , Karla Soares-Weiser supported an open letter co-authored by the European Commission (EC), the European Medicines Agency (EMA) and the Heads of Medicines Agencies (HMA), reminding clinical trial sponsors of their obligation to make their results public.  Cochrane  co-signed a letter to Norman Lamb MP, asking him to call on the UK Health Research Authority to add sanctions for noncompliance to their new research transparency policy, in line with UK Parliament recommendations. Within a few days, he responded in support of the letter and agreed to write to the HRA. Karla and members of the Cochrane Clinical Study Report Working Group also published an open letter in response to the FDA consultation on its Clinical Data Summary Report Pilot.

        In addition, Cochrane will participate in an event at the EU Parliament on transparency and clinical trials in the EU alongside representatives of EMA, the EC and several research integrity and transparency organizations – presenting the importance of trial transparency for systematic reviewers.

        A big achievement this quarter was launching 'Evidence Essentials: An introduction to evidence-based medicine and systematic reviews'. This online learning is freely available to anyone who is interested in an introduction to Evidence Based Medicine, Cochrane evidence and how to use it.

         Cochrane UK highlighted their work going into UK schools in an outreach programme to teach children about Evidence-Based Medicine and Cochrane. Cochrane also launched #BetterPoster templates for conference posters that have less text and a decluttered design with the main finding in plain English as the highlighted feature. And to help people understand what Evidence Syntheses is and why we need it, Cochrane Ireland and Evidence Synthesis Ireland produced this great video:

        Cochrane strives to a be a diverse, inclusive, and transparent international organization that effectively harnesses the enthusiasm and skills of our contributors, is guided by our principles, governed accountably, managed efficiently, and makes optimal use of its resources.

        In July, we made our 2018 Annual Review available. It highlighted Cochrane’s key achievements during 2018 and the strides being made on our major Strategy to 2020 initiatives.

        In Q4, we will be gathering for the Cochrane Santiago 2019 Colloquium, with an excellent Scientific Programme being announced. This year’s scientific program is highly focused on the over-arching Colloquium theme, ‘Embracing Diversity’, which will be carried out through plenaries from global speakers, special sessions, oral presentations, and workshops. Cochrane also announced that in 2021 we will join with JBI, Campbell Collaboration and Guidelines International Network to host of the Global Evidence Summit (GES) in the Czech Republic, Prague.

        Wednesday, October 9, 2019

        World Mental Health Day

        Wed, 10/03/2018 - 17:41

        Every year on 10 October many organisations, including the World Health Organisation (WHO), recognise World Mental Health Day. The objective is to raise awareness of mental health issues around the world and mobilize efforts in support of mental health. This year’s theme, set by the World Federation for Mental Health, is ‘Mental Health for All’. It is a timely reminder of how all of our mental health and wellbeing is being impacted as a result of the COVID-19 pandemic.

        The Cochrane Common Mental Disorders (CCMD) review group have already published several reviews of specific relevance to the COVID-19 pandemic. Examples include Psychological therapies for women who experience intimate partner violence and Behavioural activation therapy for depression in adults. The group is also expediting several other new or updated reviews.

        For some sections of the population the impact of COVID-19 on mental health could be greater, so it is important that we provide Cochrane evidence relevant to these vulnerable groups. One group of concern are children and young people, many had to adapt to long periods away from school, their friends and social networks. Young people now face much greater uncertainty about their future.

        At the Cochrane Common Mental Disorders - Children and Young People Satellite, hosted by the University of Auckland, the focus is on undertaking Cochrane Reviews on topics that are relevant to young people and their caregivers. As a first step, the satellite has conducted a cross-sectional survey with a broad range of stakeholders, these stakeholders let us know that anxiety, depression and suicide are the most important issues for young people. Respondents highlighted the complex interplay of several issues such as early home environment, lack of mental health literacy, disconnection with social environment and structural issues adversely impact on the mental health and wellbeing of children and young people.

        The gap between resources available to do research and the large range of child and youth mental health issues that need attention, means that rationalising what to focus on first is important. Ensuring meaningful engagement of stakeholders in prioritising is critical. As a next step, the satellite invites young people, their caregivers, clinicians, academic researchers and all those who work for, or care about, child and youth mental health to help them identify the ‘top 3’ research questions that the Satellite should focus their evidence synthesis on over the next few years. Take a moment on World Mental Health day to help - please share and complete the survey and pick your top-3 questions. 

        Cochrane Common Mental Disorders Group is a Review Group that  works with authors from around the world to produce and disseminate systematic reviews of healthcare interventions for treating and preventing a range of mental health problems. Some of the conditions they cover include depression, anxiety, eating disorders, somatoform disorders and suicide.

        Related resources:

        Research prioritisation: young people driving the mental health research agenda - In this Evidently Cochrane blog for mental health researchers and those interested in evidence synthesis, Sarah Hetrick and Vartika Sharma, researchers at the Cochrane Common Mental Disorders – Children and Young People Satellite (hosted by the Department of Psychological Medicine, University of Auckland, New Zealand) look at the benefits and practicalities of engaging with young people in the process of undertaking child and youth mental health research.

        Friday, October 9, 2020

        Cochrane Summer School 2019

        Mon, 10/01/2018 - 17:01

        Improving Cochrane evidence uptake in clinical practice is a joint goal of Cochrane Neurological Sciences and Cochrane Italy. They have been making progress with their annual Summer Schools. Over a week they gather young doctors to talk about clinical decision making, evidence-based medicine, and the methodology behind Cochrane Reviews.

        Thursday, November 7, 2019

        World Continence Week

        Mon, 06/18/2018 - 14:32

        World Continence Week 2019 is held between 17 and 23 June and is a global initiative run by the World Federation of Incontinence Patients (WFIP), with the approval of the International Continence Society (ICS). The vision is to help improve health, wellness and quality of life for those with continence issues, and to further establish awareness of bladder weakness, pelvic pain and other conditions that impact on the lives of patients and carers.

        Cochrane Incontinence works with authors to prepare, maintain and disseminate systematic reviews of the effectiveness of interventions for incontinence, including prevention, treatment and rehabilitation. The scope of these reviews touches on a wide variety of continence issues, including urinary and faecal incontinence, pelvic organ prolapse, the use of urinary catheters, post-operative urinary retention and night-time and daytime wetting in children.

        Below are a variety of Cochrane resources related to World Continence Week.

        Highlighted Cochrane Reviews

        1. Pelvic floor muscle training versus no treatment, or inactive control treatments, for urinary incontinence in women

        Q&A with the authors: Pelvic floor muscle training versus no treatment, or inactive control treatments, for urinary incontinence in women

        2. Interventions for treating urinary incontinence after stroke in adults

        3. Yoga for treating urinary incontinence in women

        4. Alpha blockers for treating functional daytime urinary incontinence in children (protocol): full review expected in 2020.

        5. Interventions for treating people with symptoms of bladder pain syndrome: a network meta-analysis (protocol): full review expected in 2019.

        Take a look at these Evidently Cochrane blog posts featuring Cochrane Incontinence evidence:

        Find all of Cochrane Incontinence’s reviews on the Cochrane Library.

        Friday, June 14, 2019

        The Cochrane Library App

        Sun, 03/11/2018 - 23:00

        The Cochrane Library App presents the latest up-to-date evidence from the Cochrane Library in a convenient, easy to navigate format which provides you with relevant, accessible research, when you need it, from the world’s leading experts in evidence-informed health care.

        All content in the app is free and new issues will download regularly.

        Our monthly issues feature a hand-picked selection of Cochrane Systematic Reviews, specifically chosen by the Editor-in-chief.  Abridged Cochrane Reviews provide the best possible tablet and phone reading experience and they are downloadable for reading offline. The Bookmark feature allows you to create your own special collection of Cochrane Reviews across issues. Additionally, the title page for every review includes a link to the full version of the review available on the Cochrane Library.

        The Cochrane Reviews included in this month's issue focus on a wide range of interesting topics from recent publications. Our main review this  month is ‘Interventions to reduce ambient particulate matter air pollution and their effect on health’. Ambient air pollution is associated with a large burden of disease in both high-, low‐ and middle‐income countries. It has been linked to cardiovascular and respiratory diseases. Many different policies and programmes have been put into place to reduce air pollution, including vehicle restrictions to reduce traffic, fuel standards for cars, buses and other motorized transport, and limiting pollution from factories. But so far, no review has investigated systematically whether these measures have impacted air pollution and health as intended. The authors from Cochrane Public Health Group assessed the effectiveness of interventions to reduce ambient particulate matter air pollution in reducing pollutant concentrations and improving associated health outcomes.

        Friday, June 14, 2019

        Translated Cochrane evidence

        Wed, 02/21/2018 - 04:00

         Bringing you Cochrane evidence in 15 different languages
        Many people do not have access to high quality health information, because it is not or scarcely available in a language that they understand. We are translating Cochrane evidence to make it accessible to non-English speakers, and to reduce the linguistic barrier to global evidence-informed health decisions. More than 28,000 translations of Cochrane Review plain language summaries/abstracts have been published as of June 2019. Translation activities are led by local Cochrane groups and their translator communities, the majority of which are volunteer based. Due to the length of Cochrane Reviews, our teams focus on the abstract and/or the Plain Language Summary.
        Find Cochrane evidence in different languages: Cochrane evidence is currently translated into 15 languages: Croatian, French, German, Japanese, Korean, Malay, Persian, Polish, Portuguese, Russian, Simplified Chinese, Spanish, Tamil, Thai, and Traditional Chinese. Most languages have their own version of; you can view translations by clicking on the languages that appear across the top of each page.

        Cochrane Podcasts in different languages: Cochrane podcasts offer a short summary of a recent Cochrane review and have been recorded in 38 languages.

        Most translated Reviews: The links below will take you to the English language version of our most translated Reviews. Languages these Reviews have been translated into are listed across the top of the page. To read the Review in another language, simply click on the language and it will take you to the translation.

        Our translation achievements in an infographic (see larger version in new tab):


          Monday, July 15, 2019